CS
CPXX

Credit Suisse’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Credit Suisse’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-88,087
Closed -$2.66M – 4427
2016
Q2 		$2.66M Buy
+88,087
New +$1.79M ﹤0.01% 2119

Credit Suisse's CPXX Position: Q3 2016 in Review

Credit Suisse sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 88,087 shares — an estimated $2.66M sold.

Credit Suisse first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $2.66M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Credit Suisse reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Credit Suisse sold 88,087 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $2.66M.
  • Credit Suisse first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Credit Suisse's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $2.66M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Credit Suisse's 13F filing for Q3 2016, filed 15 Nov 2016.